Results 101 to 110 of about 6,731 (217)

Antiplatelet medications in acute coronary syndromes and percutaneous coronary interventions: focus on tirofiban

open access: yesКардиоваскулярная терапия и профилактика, 2008
The review presents literature data on the key role of platelet aggregation (PA) for intracoronary thrombogenesis in various acute coronary syndromes (ACS) and percutaneous coronary interventions (PCI).
T. A. Batyraliev   +4 more
doaj  

Interventional radiology treatments for iatrogenic severe bleeding during percutaneous coronary interventions [PDF]

open access: yes, 2018
Purpose: Interventional cardiology and interventional radiology are separate medical disciplines in which intra-arterial contrast media are used. Interventional cardiology has resigned from many types of treatment techniques that are now used and ...
Brzozowski, Krzysztof   +5 more
core   +1 more source

The Evolving Pharmacotherapeutic Landscape for the Treatment of Sickle Cell Disease. [PDF]

open access: yes, 2020
Sickle cell disease (SCD) is an extremely heterogeneous disease that has been associated with global morbidity and early mortality. More effective and inexpensive therapies are needed.
Ballas, Samir K
core   +1 more source

Eptifibatide in Coronary Intervention [PDF]

open access: bronze, 2015
Matthew W. Sherwood, James E. Tcheng
openalex   +1 more source

E-059 Eptifibatide bridging therapy for staged carotid artery stenting and cardiac surgery [PDF]

open access: gold, 2021
M. Travis Caton   +9 more
openalex   +1 more source

Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction [PDF]

open access: yes, 2017
Recent clinical data show that the risk of coronary thrombosis after antiplatelet drugs withdrawal is much higher than that of surgical bleeding if they are continued.
Chassot, P.-G   +2 more
core  

Megakaryocyte impairment by eptifibatide-induced antibodies causes prolonged thrombocytopenia [PDF]

open access: bronze, 2009
Andreas Greinacher   +7 more
openalex   +1 more source

Impact of Maintenance Dose of Eptifibatide in Patients with ST-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Coronary Intervention [PDF]

open access: gold, 2022
Rozita Jalalian   +5 more
openalex   +1 more source

Investigation of interaction of human platelet membrane components with anticoagulant drugs Abciximab and Eptifibatide

open access: yesFolia Histochemica et Cytobiologica, 2010
Abciximab (Abci) and eptifibatide (Epti) are antiaggregate drugs which may reduce thrombotic complications inacute coronary syndromes. The aim of this work was the investigation of the interaction between the phospholipid-GPIIb/IIIa glycoprotein complex ...
Ewa Gorodkiewicz   +2 more
doaj  

Acute Coronary Syndromes: Management and Secondary Prevention [PDF]

open access: yes, 2018
Acute coronary syndromes represent a broad spectrum of ischemic myocardial events including unstable angina, non-ST elevation myocardial infarction and acute ST elevation myocardial infarction, which are associated with high morbidity and mortality. They
Wenaweser, Peter, Windecker, Stephan
core  

Home - About - Disclaimer - Privacy